search button

Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review

  • Authors:
    • Paola Senia
    • Francesca Vella
    • Nicola Mucci
    • George Dounias
    • Antonio Trovato
    • Andrea Marconi
    • Caterina Ledda
    • Venerando Rapisarda
    • Ermanno Vitale

  • View Affiliations

  • Published online on: October 28, 2021     https://doi.org/10.3892/etm.2021.10932
  • Article Number: 10
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

According to the Centre for Disease Control and Prevention in 2020, a cluster of pneumonia cases of unknown etiology caused by the severe acute respiratory syndrome (SARS)‑coronavirus 2 was reported in Wuhan, China. The present review examined the literature to reveal the incidence of novel coronavirus‑2019 disease (COVID‑19) infections, underlying comorbidities, workplace infections and case fatality rates. A review was performed to identify the relevant publications available up to May 15, 2020. Since the early stages of the COVID‑19 outbreak, the case fatality rate among healthcare workers (HCWs) has stood at 0.69% worldwide and 0.4% in Italy. Based on the current information, most patients have exhibited good prognoses in terms of after‑effects or sequelae and low mortality rate. Patients that became critically ill were primarily in the elderly population or had chronic underlying diseases, including diabetes and hypertension. Among all working sectors, HCWs, since they are front‑line caregivers for patients with COVID‑19, are considered to be in the high‑risk population. Increased age and a number of comorbidity factors have been associated with increased risk of mortality in patients with COVID‑19. The most frequent complications of COVID‑19 reported that can cause fatality in patients were SARS, cardiac arrest, secondary infections and septic shock, in addition to acute kidney failure and liver failure. Overcoming the COVID‑19 pandemic is an ongoing challenge, which poses a threat to global health that requires close surveillance and prompt diagnosis, in coordination with research efforts to understand this pathogen and develop effective countermeasures.
View Figures
View References

Related Articles

Journal Cover

January-2022
Volume 23 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Senia P, Vella F, Mucci N, Dounias G, Trovato A, Marconi A, Ledda C, Rapisarda V and Vitale E: Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review. Exp Ther Med 23: 10, 2022
APA
Senia, P., Vella, F., Mucci, N., Dounias, G., Trovato, A., Marconi, A. ... Vitale, E. (2022). Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review. Experimental and Therapeutic Medicine, 23, 10. https://doi.org/10.3892/etm.2021.10932
MLA
Senia, P., Vella, F., Mucci, N., Dounias, G., Trovato, A., Marconi, A., Ledda, C., Rapisarda, V., Vitale, E."Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review". Experimental and Therapeutic Medicine 23.1 (2022): 10.
Chicago
Senia, P., Vella, F., Mucci, N., Dounias, G., Trovato, A., Marconi, A., Ledda, C., Rapisarda, V., Vitale, E."Survey on COVID‑19‑related mortality associated with occupational infection during the first phase of the pandemic: A systematic review". Experimental and Therapeutic Medicine 23, no. 1 (2022): 10. https://doi.org/10.3892/etm.2021.10932